-
EP3829736
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3829736
| EP3829736 - METHOD OF FILLING AT LEAST ONE DEGASSED DRUG PRODUCT INTO CONTAINERS AND DRUG PRODUCT FILLING DEVICE [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 12.01.2024 Database last updated on 15.06.2024 | |
| Former | Grant of patent is intended Status updated on 28.11.2023 | ||
| Former | Examination is in progress Status updated on 21.10.2023 | ||
| Former | Grant of patent is intended Status updated on 29.06.2023 | ||
| Former | Examination is in progress Status updated on 24.12.2021 | ||
| Former | Request for examination was made Status updated on 07.05.2021 | ||
| Former | The international publication has been made Status updated on 01.02.2020 | ||
| Former | unknown Status updated on 03.08.2019 | Most recent event Tooltip | 12.01.2024 | (Expected) grant | published on 14.02.2024 [2024/07] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2021/23] | Inventor(s) | 01 /
BOEUF, Julien c/o Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE | 02 /
KEEHNEN, Vincent c/o Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE | 03 /
RAKEL, Natalie c/o Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE | 04 /
ULMER, Alexander c/o Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE | 05 /
ZIERES, Gerald c/o Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE | [2021/23] | Representative(s) | Altmann Stößel Dick Patentanwälte PartG mbB Theodor-Heuss-Anlage 2 68165 Mannheim / DE | [2024/07] |
| Former [2021/23] | Altmann Stößel Dick Patentanwälte PartG mbB Dudenstrasse 46 68167 Mannheim / DE | Application number, filing date | 19742774.3 | 26.07.2019 | [2021/23] | WO2019EP70198 | Priority number, date | EP20180186014 | 27.07.2018 Original published format: EP 18186014 | [2021/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020021073 | Date: | 30.01.2020 | Language: | EN | [2020/05] | Type: | A1 Application with search report | No.: | EP3829736 | Date: | 09.06.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.01.2020 takes the place of the publication of the European patent application. | [2021/23] | Type: | B1 Patent specification | No.: | EP3829736 | Date: | 14.02.2024 | Language: | EN | [2024/07] | Search report(s) | International search report - published on: | EP | 30.01.2020 | Classification | IPC: | B01D19/00, A61K9/00, B65B3/00, B65B3/22, A61M5/00 | [2021/23] | CPC: |
B01D19/0031 (EP,IL,KR,US);
B65B3/003 (EP,CN,IL,KR,US);
B65B3/22 (EP,IL,KR,US);
B01D19/00 (CN);
B01D63/031 (US);
B65B3/04 (CN);
B65B63/00 (US);
B01D2313/04 (US);
B01D2313/13 (US);
B01D2313/24 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/23]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERFAHREN ZUM ABFÜLLEN MINDESTENS EINES ENTGASTEN ARZNEIMITTELPRODUKTS IN BEHÄLTER UND ARZNEIMITTELPRODUKTABFÜLLVORRICHTUNG | [2021/23] | English: | METHOD OF FILLING AT LEAST ONE DEGASSED DRUG PRODUCT INTO CONTAINERS AND DRUG PRODUCT FILLING DEVICE | [2021/23] | French: | PROCÉDÉ DE REMPLISSAGE D'AU MOINS UN PRODUIT MÉDICAMENTEUX DÉGAZÉ DANS DES CONTENANTS ET DISPOSITIF DE REMPLISSAGE D'UN PRODUIT MÉDICAMENTEUX | [2023/26] |
| Former [2021/23] | PROCÉDÉ DE REMPLISSAGE D'AU MOINS UN PRODUIT MÉDICAMENTEUX DÉGAZÉ DANS DES RÉCIPIENTS ET DISPOSITIF DE REMPLISSAGE DE PRODUIT MÉDICAMENTEUX | Entry into regional phase | 17.02.2021 | National basic fee paid | 17.02.2021 | Designation fee(s) paid | 17.02.2021 | Examination fee paid | Examination procedure | 17.02.2021 | Examination requested [2021/23] | 17.02.2021 | Date on which the examining division has become responsible | 17.12.2021 | Amendment by applicant (claims and/or description) | 05.01.2022 | Despatch of a communication from the examining division (Time limit: M06) | 05.08.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 11.10.2022 | Reply to a communication from the examining division | 13.12.2022 | Despatch of a communication from the examining division (Time limit: M04) | 21.04.2023 | Reply to a communication from the examining division | 30.06.2023 | Communication of intention to grant the patent | 20.10.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.11.2023 | Communication of intention to grant the patent | 08.01.2024 | Fee for grant paid | 08.01.2024 | Fee for publishing/printing paid | 08.01.2024 | Receipt of the translation of the claim(s) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 11.10.2022 | Request for further processing filed | 11.10.2022 | Full payment received (date of receipt of payment) Request granted | 19.10.2022 | Decision despatched | 17.12.2021 | Request for further processing filed | 17.12.2021 | Full payment received (date of receipt of payment) Request granted | 05.01.2022 | Decision despatched | Fees paid | Renewal fee | 17.02.2021 | Renewal fee patent year 03 | 11.07.2022 | Renewal fee patent year 04 | 20.07.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]JPH0994447 (DAINIPPON INK & CHEMICALS) [X] 1-16 * fig.1, claims 1-3,14 * [I] 17,18; | [XI]US6503225 (KIRSCH CLAUDIA F E [US], et al) [X] 1-16 * fig.1,2, col.1 line 24-25, col.3 line 33 - col.5 line 22 * [I] 17,18; | [XI]US2011108158 (HUWILER CHRISTOPH [CH], et al) [X] 1-16 * fig.1,2,3A, par.14,16,43-52 *[I] 17,18 | Examination | US4636307 | US8882967 | WO2018085892 | by applicant | - GIANNOS SAKRAFT ERZHAO ZYMERKLEY KHCAI J., "Formulation Stabilization and Disaggregation of Bevaci-zumab, Ranibizumab and Aflibercept in Dilute Solutions", Pharm Res., (20180228), vol. 35, no. 4, page 78 |